Catherine M. Szyman - 07 May 2021 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Critical Care
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 07 May 2021
Net transactions value: -$235,818
Form type: 4
Filing time: 07 May 2021, 18:32:03 UTC
Next filing: 12 May 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Options Exercise	$75,530	+3,389	+11%	$22.29	34,329	07 May 2021	Direct	F1
transaction	EW	Common Stock	Sale	$311,347	-3,389	-9.9%	$91.87	30,940	07 May 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EW	Employee Stock Option (Right to Acquire)	Options Exercise	$0	-3,389	-50%	$0.000000	3,410	07 May 2021	Common Stock	3,389	$22.29	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2020.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.